| Drug Name: | Viloxazine (46817-91-8) |
|---|---|
| PubChem ID: | 5666 |
| SMILES: | CCOC1=CC=CC=C1OCC2CNCCO2 |
| InchiKey: | YWPHCCPCQOJSGZ-UHFFFAOYSA-N |
| Therapeutic Category: | Adrenergic Agents, Adrenergic Uptake Inhibitors, Antidepressive Agents, Central Nervous System Agents, Membrane Transport Modulators, Neurotransmitter Agents, Neurotransmitter Uptake Inhibitors, Psychotropic Drugs |
| Molecular Weight (dalton) | : | 237.299 |
| LogP | : | 1.4525 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 4 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 39.72 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Carbamazepine (298-46-4) | Ataxia | Synergistic | Uncertain. some suggests that viloxazine inhibits the metabolism of carbamazepine, thereby reducing its clearance and raising its serum levels. | Effect of viloxazine on serum carbamazepine levels in epileptic patients |
| Phenytoin (57-41-0) | Nystagmus | Antagonistic | Uncertain | Elevation of plasma phenytoin by viloxazine in epileptic patients: a clinically significant drug interaction |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|---|
| Mental Disorders | MetaADEDB |